Advertisement

Topics

ORGENTEC Diagnostika GmbH Company Profile

21:04 EDT 18th September 2018 | BioPortfolio

ORGENTEC Diagnostika, located in Mainz (Germany) is a privately owned and independent company, founded in 1988. From its inception, the company has been dedicated to the development and production of autoimmune ELISA test systems. Today, ORGENTEC has 70 employees (including 15 scientists) mostly involved in Research & Development and Production.Our first priority is the development of new and innovative test systems. The ORGENTEC product range is constantly expanding and now offers more than 90 highly reliable assays on enzyme immunometric and immunoblot basis, for the detection of autoantibodies.
• A continuously growing number of ELISA and immunoblot tests, designed for comprehensive ANA and ENA diagnostic for the detection of inflammatory rheumatic disease.
Thrombosis diagnostics: We are now able to offer fifteen different ELISA tests for the detection of particular Anti-Phospholipid antibodies and their corresponding isotypes, this includes not only our outstanding Anti-Cardiolipin assays, but also test systems for the detection of autoantibodies against the cofactor ß2-Glycoprotein 1.
• ANCA diagnostics: Nine different ELISA kits are available for the detection of ANCA specificities. This also includes our ANCAcombi test, an outstanding kit that permits the simultaneous detection of the most important autoantibodies, in one step.

Location

Carl-Zeiss-Straße 49
Mainz
55129
Germany

Contact

Phone: 49 - (0)6131 / 92 58 - 0
Fax: 49 - (0)6131 / 92 58 58


News Articles [165 Associated News Articles listed on BioPortfolio]

Systec GmbH Introduces its new Business Partner Evidencia GmbH

Research, pharmaceuticals, life sciences and food: many laboratories rely on steam sterilizers or equipment where processes are monitored using pressure and temperature control. Thanks to our collabor...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Merck will Genomeditierung zur Untersuchung von Darmbakterien zugunsten unterernährter Kinder einsetzen

- Kooperation mit Washington University bei Darmbakterienforschung könnte zu Diagnostika sowie Behandlung unterernährter Kinder führen - Untersuchung erfolgt unter Einsatz der Technologie zur Genom...

Laufende Fusionskontrollverfahren: Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);

Datum der Anmeldung:28.08.2018Aktenzeichen:B3-128/18Unternehmen:Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);Produktmärkte:in.....

Laufende Fusionskontrollverfahren: The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB Innere Medizin GmbH & Co. KG, Monheim (D) und die UCB Primary Care GmbH, Monheim (D);

Datum der Anmeldung:07.08.2018Aktenzeichen:B3-119/18Unternehmen:The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB In....

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

Original-Research: CO.DON AG - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu CO.DON AG Unternehmen: CO.DON AG ISIN: DE000A1K0227 Anlass der Studie: Update Report Empfehlung: Buy se...

JA Solar dodáva poločlánkové moduly pre solárne elektrárne v Afrike

Spolutvorcami projektu v Namíbii sú renomovaný nemecký developer SunEQ GmbH, sesterská spoločnosť konzultačnej firmy pre obnoviteľné zdroje energie Suntrace GmbH a popredný nový dodáva...

PH-FIX Indikatorstäbchen pH 4,5-10 100 St MACHEREY-NAGEL GMBH & CO. KG

EUR 10,24Angebotsende: Samstag Apr-7-2018 11:22:08 CESTSofort-Kaufen für nur: EUR 10,24Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : PH-FIX Indikatorstäbchen pH 4,...

PubMed Articles [9 Associated PubMed Articles listed on BioPortfolio]

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

A purpose-designed monofilament-fibre pad for debridement of hard-to-reach wounds: experience in clinical practice.

Effective and comfortable debridement is an important part of managing complex wounds. This user test evaluated a monofilament-fibre pad (with handle) (Debrisoft Lolly, Lohmann & Rauscher GmbH & Co. K...

Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder.

Photodynamic diagnosis using the optical imaging agent hexaminolevulinate (HAL, Hexvix®, Ipsen Pharma GmbH, Ettlingen, Germany) as an adjunct to white light cystoscopy (WLC) during the initial transu...

Clinical Trials [47 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Choosing a Preferred Serology Kit for Screening and Diagnosis of Celiac Disease

The investigators will perform prospective observational multicenter study which includes children with suspicion of CD who referred to gastroscopy and intestinal biopsies (study group) an...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Companies [536 Associated Companies listed on BioPortfolio]

ORGENTEC Diagnostika GmbH

ORGENTEC Diagnostika, located in Mainz (Germany) is a privately owned and independent company, founded in 1988. From its inception, the company has been dedicated to the development and production of ...

VIRO-IMMUN LABOR-DIAGNOSTIKA GmbH

Viro-Immun Labor-Diagnostika GmbH develops and produces high quality products for serological diagnosis of viral, bacterial and mycotic infections as well as test systems for serological diagnosis of ...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Abbott GmbH & Co. KG, Personalreferat GPRD

Abbott Laboratories ist mit mehr als 70.000 Mitarbeitern in 130 Ländern eines der weltweit führenden Pharma- und Diagnostika-Unternehmen. Intensive Grundlagenforschung und fokussierte Entwicklungska...

Hölzel Diagnostika

We are your partner for Elisa-Kits, Antibodies, Array-Assays and Peptides.

More Information about "ORGENTEC Diagnostika GmbH" on BioPortfolio

We have published hundreds of ORGENTEC Diagnostika GmbH news stories on BioPortfolio along with dozens of ORGENTEC Diagnostika GmbH Clinical Trials and PubMed Articles about ORGENTEC Diagnostika GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ORGENTEC Diagnostika GmbH Companies in our database. You can also find out about relevant ORGENTEC Diagnostika GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...


Corporate Database Quicklinks



Searches Linking to this Company Record